Yale spin-off company Modifi Bio acquired by Merck in multimillion dollar deal

Yale Daily News

Nov 14, 2024

On Oct. 15, Modifi Bio, a Yale-based biotech company, closed an acquisition deal with Merck, an American pharmaceutical company, with $30 million paid upfront and up to $1.3 billio…